1.
Hota M, Barber JL, Ruiz-Ramie JJ, et al. Omics-driven investigation of the biology underlying intrinsic submaximal working capacity and its trainability. Physiological genomics. 2023. doi:10.1152/physiolgenomics.00163.2022.
1.
Benson MD, Eisman AS, Tahir UA, et al. Protein-metabolite association studies identify novel proteomic determinants of metabolite levels in human plasma. Cell metabolism. 2023. doi:10.1016/j.cmet.2023.07.012.
1.
Geffen Y, Anand S, Akiyama Y, et al. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell. 2023. doi:10.1016/j.cell.2023.07.013.
1.
Li Y, Porta-Pardo E, Tokheim C, et al. Pan-cancer proteogenomics connects oncogenic drivers to functional states. Cell. 2023. doi:10.1016/j.cell.2023.07.014.
1.
Zhang F, Luna A, Tan T, Chen Y, Sander C, Guo T. COVIDpro: Database for Mining Protein Dysregulation in Patients with COVID-19. Journal of proteome research. 2023. doi:10.1021/acs.jproteome.3c00092.
1.
Katz DH, Tahir UA, Bick AG, et al. Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease. Circulation. 2022;145(5):357-370. doi:10.1161/CIRCULATIONAHA.121.055117.
1.
Yang R, Meyer AS, Droujinine IA, et al. A genetic model for proximity labelling of the mammalian secretome. Open Biol. 2022;12(8):220149. doi:10.1098/rsob.220149.
1.
Anurag M, Jaehnig EJ, Krug K, et al. Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. Cancer Discov. 2022;12(11):2586-2605. doi:10.1158/2159-8290.CD-22-0200.
1.
Shuster A, Li J, Chon U, et al. In situ cell-type-specific cell-surface proteomic profiling in mice. Neuron. 2022;110(23):3882-3896.e9. doi:10.1016/j.neuron.2022.09.025.
1.
Liu S, Marneth AE, Alexe G, et al. The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy. Blood Adv. 2018;2(23):3428-3442. doi:10.1182/bloodadvances.2018016733.